Treatment with Scemblix demonstrated superior results versus treatment with standard-of-care TKIs in some patients with chronic myeloid leukemia.Treatment ...

The JAK inhibitors approved for myelofibrosis have common side effects of cytopenias and gastrointestinal issues, with additional risks of weight gain and ...

Desmond Tutu once said, “Hope is being able to see that there is light despite all the darkness.” This quote signifies how I felt on February 20, 2020. On ...

A novel drug demonstrated promising benefits for patients with pretreated Waldenstrom’s macroglobulinemia, a subtype of non-Hodgkin lymphoma. The novel ...

Response is assessed in patients starting a JAK inhibitor by monitoring symptoms on a severity scale, spleen size, blood counts, and overall patient ...

More needs to be done to facilitate a connection between oncology nurse navigators and clinical resources to improve enrollment and diversify the patient ...

In the fall of 2022, I was diagnosed with high grade stage 2 B-cell non-specific, non-Hodgkin lymphoma, a rare blood cancer in which B cells mutate and ...

Research has found that next-generation sequencing may be better able to detect DNA mismatch repair.Most patients with endometrial or colorectal cancer ...

In the summer of 1987, I was in my second year of graduate school in the Department of English at Iowa State University in Ames, Iowa. We were having a heat ...

The addition of immunotherapy to chemotherapy trended toward improved GI cancer outcomes, though not all outcomes had a statistically significant ...

The year 2024 is now underway. After a busy 2023, we’re now looking back at some of the oncology headlines from the new year.Notably, we have a clinical ...

Possibly more appealing is to hunt the underlying mechanism for the genetic instability that causes the CNA (or any other cancer hallmark) to occur. It ...